EU committee recommends daraxonrasib for metastatic pancreatic cancer

Europe’s CHMP recommends daraxonrasib for pancreatic cancer, HHS and the FDA send a peptide compounding policy to the White House, and the EU committee backs Lilly’s GLP-1 pill.